Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.

dc.contributor.author

Zhang, Fenghua

dc.contributor.author

Sturgis, Erich M

dc.contributor.author

Sun, Yan

dc.contributor.author

Zhang, Yang

dc.contributor.author

Wei, Qingyi

dc.contributor.author

Zhang, Caiyun

dc.contributor.author

Zheng, Hongliang

dc.contributor.author

Li, Guojun

dc.coverage.spatial

United States

dc.date.accessioned

2015-10-07T16:37:30Z

dc.date.issued

2015-11-15

dc.description.abstract

Single nucleotide polymorphisms (SNPs) in the promoter region of FAS and FASLG may alter their transcriptional activity. Thus, we determined the associations between four FAS and FASLG promoter variants (FAS1377G>A, rs2234767; 670A>G, rs1800682; FASLG844T>C, rs763110 and 124A>G, rs5030772) and the risk of recurrence of squamous cell carcinoma of the oropharynx (SCCOP). We evaluated the associations between FAS and FASLG genetic variants and the risk of recurrence in a cohort of 1,008 patients. The log-rank test and multivariate Cox models were used to evaluate the associations. Compared with patients with common homozygous genotypes of FAS670 and FASLG844 polymorphisms, patients with variant genotypes had lower disease-free survival rates (log-rank p < 0.0001 and p < 0.0001, respectively) and an approximately threefold higher risk of SCCOP recurrence (HR, 3.2;95% CI, 2.2-4.6; and HR, 3.1; 95% CI, 2.2-4.4, respectively) after multivariate adjustment. Furthermore, among patients with HPV16-positive tumors, those with variant genotypes of these two polymorphisms had lower disease-free survival rates (log-rank, p < 0.0001 and p < 0.0001, respectively) and a higher recurrence risk than did patients with common homozygous genotypes (HR, 12.9; 95% CI, 3.8-43.6; and HR, 8.1; 95% CI, 3.6-18.6, respectively), whereas no significant associations were found for FAS1377 and FASLG124 polymorphisms. Our findings suggest that FAS670 and FASLG844 polymorphisms modulate the risk of recurrence of SCCOP, particularly in patients with HPV16-positive tumors. Larger studies are needed to validate these results.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/25976983

dc.identifier.eissn

1097-0215

dc.identifier.uri

https://hdl.handle.net/10161/10674

dc.language

eng

dc.publisher

Wiley

dc.relation.ispartof

Int J Cancer

dc.relation.isversionof

10.1002/ijc.29604

dc.subject

FAS and FASLG

dc.subject

apoptosis

dc.subject

biomarkers

dc.subject

genetic variants

dc.subject

head and neck cancer

dc.subject

human papillomavirus

dc.subject

oropharyngeal cancer

dc.subject

recurrence

dc.subject

Adult

dc.subject

Aged

dc.subject

Aged, 80 and over

dc.subject

Antigens, CD95

dc.subject

Carcinoma, Squamous Cell

dc.subject

Cohort Studies

dc.subject

Fas Ligand Protein

dc.subject

Female

dc.subject

Genetic Association Studies

dc.subject

Humans

dc.subject

Male

dc.subject

Middle Aged

dc.subject

Neoplasm Recurrence, Local

dc.subject

Oropharyngeal Neoplasms

dc.subject

Papillomavirus Infections

dc.subject

Polymorphism, Single Nucleotide

dc.subject

Survival Analysis

dc.title

Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.

dc.type

Journal article

duke.contributor.orcid

Wei, Qingyi|0000-0002-3845-9445

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/25976983

pubs.begin-page

2454

pubs.end-page

2461

pubs.issue

10

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Medical Oncology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

137

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
WeiQ-Apopt-OPC-ZhangF-2015-IJC.pdf
Size:
281.22 KB
Format:
Adobe Portable Document Format
Description:
Published version